Cite
HARVARD Citation
Grau‐Pérez, M. et al. (2023). Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study. Journal of the European Academy of Dermatology and Venereology. pp. e678-e680. [Online].